Xinghong Gao | Immunology and Microbiology | Best Researcher Award

Prof. Xinghong Gao | Immunology and Microbiology | Best Researcher Award

Professor from Zunyi Medical University, China

Prof. Xinghong Gao is a distinguished Chinese virologist and Associate Professor at the School of Basic Medical Sciences, Zunyi Medical University. With over 15 years of research experience in molecular virology, Prof. Gao has dedicated her career to advancing our understanding of herpesviruses (KSHV, VZV, EBV, DEV, PRV) and enteroviruses (EV71, CVB3), especially focusing on epigenetic regulation of viral pathogenesis and the development of next-generation mRNA vaccines. She has led and completed over 10 national and provincial research projects and has published extensively in high-impact international journals such as Cell Death & Disease, International Journal of Biological Macromolecules, and Journal of Medical Virology. Her current research emphasizes the design of lyophilized, self-assembling nanoparticle mRNA vaccines with multivalent, high-efficiency, and low-toxicity properties, aimed at protecting both humans and animals from viral threats. Beyond research, Prof. Gao plays a critical role in teaching, mentoring, academic evaluation, and patent innovation. Her integration of virology, immunology, epigenetics, and bioengineering marks her as a leader in translational and preventive medicine. She is also actively involved in academic communities and serves as a reviewer and evaluator for journals, government agencies, and scientific committees.

Professional Profile

Education

Prof. Xinghong Gao earned her academic degrees in veterinary and biomedical sciences through a rigorous and continuous path of study in China. She began her academic journey with a Bachelor of Science in Veterinary Medicine from the College of Animal Science and Technology, Southwest University, Chongqing, from 2005 to 2009. Driven by a strong interest in virology and immunology, she pursued an integrated master’s and doctoral program (硕博连读) at the College of Veterinary Medicine, Sichuan Agricultural University, from 2009 to 2015, under the supervision of Prof. Renyong Jia. Her Ph.D. focused on preventive veterinary medicine, during which she conducted in-depth research on duck enteritis virus (DEV) and developed specialized knowledge in viral gene function and immune response mechanisms. In 2019–2020, she expanded her international exposure as a visiting scholar at the Department of Microbiology, University of Pittsburgh, USA, working under Prof. Shoujiang Gao. There, she gained advanced expertise in human herpesvirus (KSHV) pathogenesis and epigenetic regulation, further refining her molecular biology skills and laying the foundation for her ongoing work in human-animal viral infections and mRNA vaccine development.

Professional Experience

Prof. Xinghong Gao has served as Associate Professor at the School of Basic Medical Sciences, Zunyi Medical University, since January 2016. In this role, she has undertaken significant responsibilities in research, teaching, and graduate supervision. Between September 2019 and September 2020, she completed a year-long academic exchange at the University of Pittsburgh, USA, where she joined the microbiology research group of Prof. Shoujiang Gao, a renowned expert in Kaposi’s sarcoma-associated herpesvirus (KSHV). Her international experience solidified her expertise in herpesvirus biology and single-cell epigenetic analysis. At Zunyi Medical University, she leads several key research projects funded by national, provincial, and enterprise grants, many of which focus on the design of self-assembling mRNA vaccines targeting porcine and human viruses. Additionally, she teaches undergraduate and graduate courses such as pharmacology, microbiology, biosafety, and molecular biology techniques. She has also contributed to educational innovation through bilingual teaching and e-learning integration. Prof. Gao actively participates in administrative and scholarly roles, including grant and thesis evaluation, peer review, and national examination panels. Her practical approach to interdisciplinary science and teaching has earned her recognition as a versatile scholar, bridging fundamental research and public health applications.

Research Interests

Prof. Xinghong Gao’s research primarily focuses on virology, with specific expertise in the molecular mechanisms of herpesvirus and enterovirus infections. She is particularly interested in the role of epigenetic modifications—especially m6A methylation—in regulating viral replication, latency, and host-pathogen interactions. Her work with human and animal viruses (KSHV, VZV, EBV, PRV, DEV, EV71, and CVB3) aims to identify novel therapeutic and preventive strategies. A significant portion of her current research is dedicated to the development of mRNA-based vaccines using self-assembling ferritin nanoparticle delivery systems. These vaccines are designed to be multivalent, thermally stable, and low in toxicity, targeting diseases such as hand-foot-mouth disease, pseudorabies, and porcine diarrhea. Prof. Gao also explores the antiviral potential of natural compounds, including Chinese herbal formulations, further bridging traditional medicine with modern biomedical research. She integrates multi-omics methods, including transcriptomics, proteomics, methylomics, and immunomics, to gain comprehensive insights into virus-host interactions. This integrative approach allows her to develop innovative solutions to complex virological problems, with translational applications in public health, veterinary medicine, and biotechnology.

Research Skills

Prof. Gao possesses extensive technical expertise across molecular virology, vaccine development, and bioinformatics. She is skilled in a wide array of laboratory techniques, including mRNA in vitro transcription, lentiviral vector construction, single-cell and bulk transcriptomics, protein purification, and antibody generation. She is also proficient in advanced experimental methods such as co-immunoprecipitation, CRISPR-based detection, yeast two-hybrid screening, RNA interference, and RACE cloning. Her deep experience in multi-omics technologies spans DNA/RNA methylation profiling (m6A epitranscriptomics), proteomics, and full-transcriptome sequencing, which she applies to decipher the regulatory landscapes of viral pathogenesis. In vaccine research, she excels in the design and characterization of mRNA-LNP (lipid nanoparticle) platforms, particularly for lyophilized nanoparticle-based vaccines targeting herpesviruses and enteroviruses. Moreover, she has practical knowledge of cellular immunology, viral infection models, and biosafety evaluations. Prof. Gao’s technical foundation is strengthened by her fluency in scientific computing and statistical analysis. Her methodological breadth, paired with theoretical depth, enables her to lead interdisciplinary research projects and translate molecular insights into clinical and veterinary applications.

Awards and Honors

Prof. Xinghong Gao’s research excellence and academic contributions have earned her numerous awards and distinctions. She has been selected as an expert reviewer for national and provincial science foundations, including the Ministry of Science and Technology of China, the Guizhou Provincial Health Commission, and the Guangxi Provincial Department of Science and Technology. Her recognition as a trusted evaluator reflects her authority in the fields of virology, immunology, and molecular biology. She is a member of prominent professional societies such as the Chinese Society for Microbiology, Chinese Society of Immunology, Chinese Pharmacological Society, and Virology Branch of the Chinese Medical Association. Prof. Gao serves as a peer reviewer for top-tier SCI journals, including Journal of Medical Virology and Molecular Biology Reports. She is also listed as an expert in undergraduate thesis evaluation and is part of Guizhou’s high school examination panel. Additionally, she holds two authorized Chinese utility patents and is preparing an invention patent for a CRISPR-based rapid detection system. These accolades affirm her standing as a dynamic and impactful contributor to biomedical research and education in China.

Conclusion

Prof. Xinghong Gao is an accomplished biomedical researcher with a focused trajectory in molecular virology and vaccine innovation. Her dedication to exploring viral pathogenesis, epigenetic regulation, and advanced vaccine technology has produced significant scientific outputs and translational applications. With more than 15 years of hands-on research experience and a strong foundation in both veterinary and medical sciences, she has contributed over 20 high-quality publications, secured multi-level funding, and led groundbreaking work in mRNA vaccine development. Her teaching, mentoring, and technical skills further enhance her profile as a well-rounded scholar. Prof. Gao’s research aligns with critical global health priorities, including emerging viral infections and zoonotic disease control. Her contributions extend beyond laboratory success into educational reform, patent innovation, and community impact. As a result, she is not only a valuable asset to Zunyi Medical University but also a leading candidate for national and international recognition. Her profile exemplifies the integration of academic excellence, applied research, and interdisciplinary collaboration. With continued support and visibility, Prof. Gao is poised to play a transformative role in advancing preventive virology and translational biomedicine.

Publications Top Notes

  1. Title: mRNA vaccines: Emerging opportunities for herpesvirus prevention and therapeutic intervention
    Authors: Wenjie Cai, Mingsheng Cai, Mingsong Wu⁎, Xinghong Gao*
    Journal: International Journal of Biological Macromolecules, 2025

  2. Title: BSRF1 modulates IFN-β-mediated antiviral responses… in Epstein-Barr virus infection
    Authors: Shengwen Chen#, Yangxi Deng#, Chen Huang#, Xiaolei Xie#, Zhiwei Long, … Xinghong Gao, … Xi Lv(), Mingsheng Cai(), Meili Li(*)
    Journal: International Journal of Biological Macromolecules, 2025, 306: 141600

  3. Title: The advances of in vitro RNA preparation by single-subunit RNAP: A review
    Authors: Yuan Shen#, Dong-Qi Yang#, Yuan Liu, … Xinghong Gao*, Heng Xia*
    Journal: International Journal of Biological Macromolecules, 2025, 141002

  4. Title: Pregnancy induced hypertension and umbilical cord blood DNA methylation in newborns: An epigenome-wide study
    Authors: Xiaojun Zhu, Peiyue Jiang, Xia Ying, … Xinghong Gao*, Xiaofu Yang*
    Journal: BMC Pregnancy and Childbirth, 2024, 24(1): 433

  5. Title: METTL16 controls KSHV replication by regulating S-adenosylmethionine cycle
    Authors: Zhang Xinquan, Meng Wen, Feng Jian, Gao Xinghong, … Gao Shoujiang*
    Journal: Cell Death & Disease, 2023, 14(9): 591

  6. Title: Advances in mRNA vaccines for viral diseases
    Authors: Yukai Huang#, Xuerui Zhu#, Xiao Guo#, … Xinghong Gao*(通讯)
    Journal: Journal of Medical Virology, 2023, 95(7): e28924

  7. Title: Revolutionizing viral disease vaccination: Non-replicating mRNA vaccines
    Authors: Xiao Guo#, Dongying Liu#, Yukai Huang#, … Xinghong Gao*(通讯)
    Journal: Virology Journal, 2023, 20(1): 1–17

  8. Title: The crosstalk between classic signaling, ncRNAs, and ferroptosis in drug resistance
    Authors: Yang Liangyu, Chen Lei, Chen Tingting, Xinghong Gao*(通讯), Yongai Xiong*
    Journal: Cellular Signalling, 2023, 102: 110538

  9. Title: Identification of targets of JS-K against HBV-positive HepG2.2.15 cells using iTRAQ proteomics
    Authors: Liu Zhengyun, Xu Yan, Zhang Wanling, Gao Xinghong, …
    Journal: Scientific Reports, 2021, 11(1): 10381

  10. Title: Duck enteritis virus (DEV) UL54 protein interacts with DEV UL24 protein
    Authors: Xinghong Gao (First author), Renyong Jia*, Mingshu Wang, … Anchun Cheng*
    Journal: Virology Journal, 2017, 14(1): 166

Jean-Michel Bolla | Immunology and Microbiology | Best Researcher Award

Dr. Jean-Michel Bolla | Immunology and Microbiology | Best Researcher Award

Dr. Jean Michel Bolla is a distinguished researcher specializing in microbiology, biochemistry, and antibiotic resistance. With over 30 years of experience, he has made significant contributions to understanding bacterial resistance mechanisms, particularly efflux-mediated resistance in Gram-negative bacteria. As the Director of Research at Inserm U-1261, he has led pioneering studies in bacterial physiology and virulence, as well as the development of screening platforms for antibiotic-resistant bacteria. His leadership in the Bac-Screen platform, which enables high-throughput screening of antimicrobial compounds, highlights his commitment to innovative research. Dr. Bolla has supervised multiple PhD students and postdoctoral researchers, securing major research funding from national and international agencies. His work has been recognized through invited talks at international conferences and a patent related to diagnostic tools for antibiotic resistance. Additionally, he has contributed significantly to academia through teaching roles at Aix-Marseille Université and Université de Corse. His research continues to shape the field of antimicrobial resistance, addressing one of the most pressing global health challenges. Through his expertise, leadership, and dedication to scientific advancement, Dr. Bolla has established himself as a leading figure in microbiology and antibiotic resistance research.

Professional Profile

Education

Dr. Jean Michel Bolla holds a PhD in Biochemistry and Molecular Biology from UPR9027 CNRS, Marseille, awarded in 1990. His doctoral research focused on protein export and assembly in Escherichia coli, conducted under the supervision of Dr. JM Pagès. Following his PhD, he pursued a postdoctoral fellowship at Inserm-APHP, Paris, where he worked on iron starvation responses in Listeria monocytogenes under Dr. P. Berche. His advanced training includes specialization in Campylobacter porins at the Laboratory Centre for Disease Control in Ottawa and Winnipeg, Canada in 1997 and 1998. In 2001, he obtained his Habilitation à Diriger des Recherches (HDR) from the Faculty of Medicine, Timone, Marseille, enabling him to supervise doctoral research. His extensive academic training has provided him with a strong foundation in molecular microbiology, biochemistry, and antibiotic resistance. Through continuous education and research, Dr. Bolla has developed a deep understanding of bacterial physiology, antimicrobial resistance mechanisms, and drug discovery. His educational background has been instrumental in shaping his career as a leading researcher in microbiology and antibiotic resistance, allowing him to contribute groundbreaking insights to the field.

Professional Experience

Dr. Jean Michel Bolla has had an illustrious career in research, spanning over three decades. He began as a postdoctoral researcher at Inserm-APHP, Paris, before joining Inserm as a Chargé de Recherche in 1992. Over the years, he advanced within Inserm, holding key research positions, and became Director of Research at U-1261 in 2018. He has led major research initiatives, including the establishment of the Bac-Screen platform, a high-throughput screening system for antibiotic resistance studies. From 2007 to 2011, he also served as an Associate Professor at the Université de Corse, where he contributed significantly to teaching and student mentorship. Throughout his career, Dr. Bolla has supervised seven PhD students and three postdoctoral researchers, demonstrating his commitment to training future scientists. He has been an invited speaker at multiple international conferences, sharing his expertise in antibiotic resistance. His ability to secure major research funding, including grants from CNRS, ANR, and FEAMPA, underscores his impact in the field. His leadership roles at Inserm and collaborations with various research institutions have solidified his reputation as an expert in microbiology and antibiotic resistance.

Research Interest

Dr. Jean Michel Bolla’s research primarily focuses on antibiotic resistance mechanisms, with a particular emphasis on efflux-mediated resistance in Gram-negative bacteria. His work explores the physiology and virulence of bacterial pathogens, including Campylobacter jejuni and Listeria monocytogenes. He is deeply involved in drug discovery and screening technologies, having developed the Bac-Screen platform to identify novel antimicrobial compounds and assess their mechanisms of action. His research also extends to bacterial membrane permeability, studying how bacterial outer membrane porins influence antibiotic uptake and resistance. More recently, he has been engaged in synthetic antibacterial polymer development for therapeutic applications. His work contributes to understanding multidrug resistance mechanisms, a major global health challenge, and seeks innovative solutions to combat bacterial infections. Additionally, he collaborates on projects involving diagnostic tools for detecting antimicrobial resistance, aiming to improve early detection and treatment strategies. Through his research, Dr. Bolla strives to bridge the gap between basic microbiology and clinical applications, working towards the development of effective antimicrobial strategies to tackle the increasing threat of drug-resistant bacteria worldwide.

Research Skills

Dr. Jean Michel Bolla possesses a diverse range of research skills, with expertise in molecular microbiology, biochemistry, and antimicrobial resistance. He has extensive experience in protein purification, bacterial physiology studies, and genetic manipulation of bacterial pathogens. His work in high-throughput screening techniques has been pivotal in identifying new inhibitors for efflux pumps in Gram-negative bacteria. He is proficient in drug discovery methodologies, including antibiotic susceptibility testing, mode-of-action studies, and bacterial membrane permeability analysis. Additionally, he has expertise in structural and functional analysis of bacterial outer membrane proteins, which play a crucial role in drug resistance. Dr. Bolla is also skilled in cell culture techniques, bioinformatics, and statistical analysis for interpreting large-scale screening data. His ability to secure major research funding highlights his competence in grant writing and project management. Furthermore, his teaching and mentorship experience demonstrate his ability to train and guide students in advanced microbiology research techniques. His research skills make him a valuable asset in the fight against antimicrobial resistance, as he continues to develop innovative solutions to combat bacterial infections.

Awards and Honors

Dr. Jean Michel Bolla has been recognized for his outstanding contributions to microbiology and antibiotic resistance research. In 2007, he was awarded the Inserm-Université Interface Contract, acknowledging his excellence in research and academic collaboration. His work in antimicrobial resistance has also been recognized through significant research grants from CNRS, ANR, and FEAMPA, underscoring the impact of his studies in drug discovery and bacterial resistance mechanisms. In 2019, his Bac-Screen platform was designated an Aix-Marseille University Technological Platform, a prestigious recognition that was renewed in 2023 for its critical role in antibiotic resistance research. His contributions to the field have also led to an international patent (WO 2023/139263 A1) for a diagnostic tool to detect drug resistance. Additionally, he has been an invited speaker at leading scientific conferences, including GRS-GRC Multidrug Efflux Systems and The 3rd International Electronic Conference on Antibiotics. His expertise and dedication to advancing microbial research have positioned him as a leading scientist in his field, earning him widespread recognition and respect.

Conclusion

Dr. Jean Michel Bolla is a highly accomplished microbiologist with a strong research background in antibiotic resistance and bacterial physiology. His contributions to understanding efflux-mediated resistance in Gram-negative bacteria have had a profound impact on the field. As Director of Research at Inserm U-1261, he has demonstrated exceptional leadership, securing major research funding and spearheading innovative screening platforms for antimicrobial resistance studies. His dedication to mentoring PhD students and postdoctoral researchers underscores his commitment to advancing scientific knowledge. Through his numerous research projects, international collaborations, and conference presentations, he continues to make significant strides in addressing the global challenge of antibiotic resistance. His patent for a diagnostic tool in antimicrobial resistance showcases his ability to translate research into real-world applications. Recognized through awards and honors, Dr. Bolla is a leading expert in microbiology and antimicrobial resistance. His work has positioned him as a key figure in drug discovery and bacterial resistance research, making him a strong contender for the Best Researcher Award. His career is a testament to scientific excellence, innovation, and dedication to global health challenges.

Publications Top Notes

  1. Title: RND Efflux Pump Induction: A Crucial Network Unveiling Adaptive Antibiotic Resistance Mechanisms of Gram-Negative Bacteria
    Authors: M. Novelli, Marine; J.M. Bolla, Jean Michel
    Year: 2024
    Citations: 5

  2. Title: Design and Synthesis of Novel Amino and Acetamidoaurones with Antimicrobial Activities
    Authors: A. Di Maio, Attilio; H. Olleik, Hamza; É. Courvoisier-Dezord, Élise; M. Maresca, Marc; M. Robin, Maxime
    Year: 2024
    Citations: 1

  3. Title: Antitubercular potential and pH-driven mode of action of salicylic acid derivatives
    Authors: J. Laudouze, Janïs; T. Francis, Thomas; E. Forest, Emma; P. Santucci, Pierre; J.F. Cavalier, Jean-François
    Year: 2024

  4. Title: Synthesis and antimicrobial testing of 5-fluorouracil derivatives
    Authors: M.U. Patil, Mrunal Unmesh; S. Krykun, Serhii; F. Garzino, Frédéric; J.M. Bolla, Jean Michel; M. Camplo, Michel
    Year: 2023
    Citations: 5

  5. Title: The membrane-active polyaminoisoprenyl compound NV716 re-sensitizes Pseudomonas aeruginosa to antibiotics and reduces bacterial virulence
    Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; M. Preusse, Matthias; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
    Year: 2022
    Citations: 11

  6. Title: An Original and Efficient Antibiotic Adjuvant Strategy to Enhance the Activity of Macrolide Antibiotics against Gram-Negative Resistant Strains
    Authors: A. Troudi, Azza; J.M. Bolla, Jean Michel; N. Klibi, Naouel; J.M. Brunel, Jean Michel
    Year: 2022
    Citations: 4

  7. Title: The polyamino-isoprenyl potentiator NV716 revives disused antibiotics against Gram-negative bacteria in broth, infected monocytes, or biofilms, by disturbing the barrier effect of their outer membrane
    Authors: G. Wang, Gang; J.M. Brunel, Jean Michel; H. Rodríguez-Villalobos, Héctor; J.M. Bolla, Jean Michel; F. van Bambeke, Francoise
    Year: 2022
    Citations: 6

  8. Title: Nanoarchitectonics of Electrically Activable Phosphonium Self-Assembled Monolayers to Efficiently Kill and Tackle Bacterial Infections on Demand
    Authors: S. Carrara, Serena; F. Rouvier, Florent; S. Auditto, Sanjana; J.M. Bolla, Jean Michel; J.M. Raimundo, Jean Manuel
    Year: 2022
    Citations: 6